Examining Allarity Therapeutics Inc (ALLR)’s cash flow and debt position

In the latest session, Allarity Therapeutics Inc (NASDAQ: ALLR) closed at $0.27 down -11.96% from its previous closing price of $0.30. In other words, the price has decreased by -$0.0360 from its previous closing price. On the day, 519752 shares were traded.

Ratios:

For a deeper understanding of Allarity Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.14 and its Current Ratio is at 0.14.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLR now has a Market Capitalization of 1.86M and an Enterprise Value of 4.74M.

Stock Price History:

Over the past 52 weeks, ALLR has reached a high of $154.40, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 0.3994, while the 200-Day Moving Average is calculated to be 1.4637.

Shares Statistics:

For the past three months, ALLR has traded an average of 130.34K shares per day and 158.52k over the past ten days. A total of 5.89M shares are outstanding, with a floating share count of 5.49M. Insiders hold about 11.12% of the company’s shares, while institutions hold 0.94% stake in the company. Shares short for ALLR as of Mar 15, 2024 were 614.25k with a Short Ratio of 4.71, compared to 640.25k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.94% and a Short% of Float of 9.94%.

Earnings Estimates

There are 1 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.53 for the current quarter, with a high estimate of -$0.53 and a low estimate of -$0.53, while EPS last year was -$177.2. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.28 and low estimates of -$0.28.

Analysts are recommending an EPS of between -$1.43 and -$1.43 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.52, with 1 analysts recommending between -$1.52 and -$1.52.

Most Popular

[the_ad id="945"]